Prescription drug benefits impact of Medicare HMOs' use of formularies on beneficiaries : statement of William J. Scanlon, Director, Health Financing and Public Health Issues, Health, Education, and Human Services Division, before the Special Committee on Aging, U.S. Senate.

Prescription drug benefits [microform] : impact of Medicare HMOs' use of formularies on beneficiaries : statement of William J. Scanlon, Director, Health Financing and Public Health Issues, Health, Education, and Human Services Division, before the Special Committee on Aging, U.S. Senate.

Saved in:
Bibliographic Details
Main Author: Scanlon, William
Corporate Authors: United States. Congress. Senate. Special Committee on Aging, United States. General Accounting Office
Other title:Impact of Medicare HMOs' use formularies on beneficiaries.
Format: Government Document Microfilm Book
Language:English
Published: Washington, D.C. : [Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) :] : The Office ; [The Office, distributor], [1999]
Series:Testimony ; GAO/T-HEHS-99-171.
Subjects:
Medicare+Choice Program (U.S.)
Drugs > United States > Cost control.
Health maintenance organizations > United States.
Medicare.
Prescription pricing > United States.

Norlin Library - Government Information - Microform

Holdings details from Norlin Library - Government Information - Microform
Call Number: GA 1.5/2:T-HEHS-99-171
GA 1.5/2:T-HEHS-99-171 Restricted Place a Hold

Similar Items